The alterations of immunological reactivity in heroin addicts and their normalization in patients maintained on methadone

Folia Biologica

Volumn 50, Issue 1, 2004, Pages 24-28

  Zajícová, Alena ^a,b   Wilczek, H ^b   Holan V ^a,b  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cytokine production; Heroin; Methadone; Peripheral blood leukocytes; Proliferation

Indexed keywords

CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; METHADONE;

ADULT; ARTICLE; BLOOD DONOR; CELL PROLIFERATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEROIN DEPENDENCE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MAINTENANCE THERAPY; MALE; PERIPHERAL BLOOD STEM CELL;

EID: 18544400622     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bayer, B. M., Gastonguay, M. R., Hernandez, M. C. (1992) Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility. Immunopharmacology 23, 117-124.
2. Bryant, H. U., Bernton, E. W., Holaday, J. W. (1987) Immunosuppressive effects of chronic morphine treatment in mice. Life Sci. 41, 1731-1738.
3. Beilin, B., Shavit, Y., Trabekin, E., Mordashev, B., Mayburd, E., Zeidel, A. (2003) The effect of postoperative pain management on immune response to surgery. Anesth. Analg. 97, 822-827.
4. Bossong, H., Scheerer, S. (1989) Metadon-Behandlung in der Bundesrepublik. In: Drugs and Drug-policy, eds. Scheerer, S., Vogt, I., pp. 333-345, Campus, Frankfurt/New York.
5. Brugo, M. A., Guffanti, A., Guzzetti, S., Pedretti, D., Stringhetti, M., Confalonieri, F. (1983) Difference in the behavior of T-lymphocyte populations in heroin and methadone addicts. Boll. Ist. Sieroter Milan 62, 517-523.
6. Eisenstein, T. K., Hilburger, M. E. (1998) Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations. J. Neuroimmunol. 83, 36-44.
7. Fecho, K., Maslonek, K. A., Dykstra, L. A., Lysle, D. T. (1996) Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther. 277, 633-645.
8. Govitrapong, P., Sittitum, T., Kotchabhakdi, N., Uneklabh, T. (1998) Alterations of immune functions in heroin addicts and heroin withdrawal subjects. J. Pharmacol. Exp. Ther. 286, 883-889.
9. Holáň, V., Zajícová, A., Krulová, M., Blahoutová, V., Wilczek, H. (2003) Augmented production of proinflammatory cytokines and accelerated allotransplantation reactions in heroin-treated mice. Clin. Exp. Immunol. 132, 40-45.
10. Houghtling, R. A., Mellon, R. D., Tan, R. J., Bayer, B. M. (2000) Acute effects of morphine on blood lymphocyte proliferation and plasma IL-6 levels. Ann. N Y Acad. Sci. 917, 771-777.
11. Kim, M. H., Hahm, T. S. (2001) Plasma levels of interleukin-6 and interleukin-10 are affected by ketorolac as an adjuct to patient-controlled morphine after abdominal hysterectomy. Clin. J. Pain. 17, 72-77.
12. Kreek, M. J., Koob, G. F. (1998) Drug dependency. Drug Alc. Dep. 51, 23-47.
13. Louria, D. B., Hensle, T., Rose, J. (1967) The major medical complications of heroin addiction. Ann. Intern. Med. 67, 1-22.
14. Lysle, D. T., Coussons, M. E., Watts, V. J., Bennett, E. H., Dykstra, L. A. (1993) Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone. J. Pharmacol. Exp. Ther. 265, 1071-1078.
15. McFarlane, A. S., Peng, X., Meissler, J. J. Jr., Rogers, T. J., Geller, E. B., Adler, W. W., Eisenstein, T. K. (2000) Morphine increases susceptibility to oral Salmonella typhimurium infection. J. Infect. Dis. 181, 1350-1358.
16. McLachlan, C., Crofts, N., Wodak, A., Crowe, S. (1993) The effects of methadone on immune function among injecting drug users: a review. Addiction 88, 257-263.
17. Nelson, C. J., Schneider, G. M., Lysle, D. T. (2000) Involvement of central mu- but not delta- or kappa- opioid receptors in immunomodulation. Brain Behav. Immun. 14, 170-184.
18. Nelson, C. J., Lysle, D. T. (2001) Morphine modulation of the contact hypersensitivity response: characterization of immunological changes. Clin. Immunol. 98, 370-377.
19. Novick, D. M., Ochshorn, M., Ghali, V., Croxson, T. S., Mercev, W. D., Chiorazzi, N., Kreek, M. J. (1989) Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. J. Pharmacol. Exp. Ther. 250, 606-610.
20. Pacifici, R., Di Carlo, S., Bacosi, A., Pichini, S., Zuccaro, P. (2000) Pharmacokinetics and cytokine production in heroin and morphine-treated mice. Int. J. Immunopharmacol. 22, 603-614.
21. Payte, J. T. A. (1991) Brief history of methadone in the treatment of opioid dependence. A personal perspective. J. Psychoactive Drugs 23, 103-107.
22. Peng, X., Zhou, W., Cao, D., Liu, C., Li, Z. (1999) Changes and significance of natural killer cells, IL-2, IL-6 and TNF-α in heroin addicts after detoxification. Hua Xi Yi Ke Da Xue Xue Bao 30, 449-451. (in Chinese)
23. Peng, X., Mosser, D., Adler, M. W., Rogers, T. J., Meisser, J. J., Eisenstein, T. K. (2000) Morphine enhances interleukin-12 and the production of pro-inflammatory cytokines in mouse peritoneal macrophages. J. Leukoc. Biol. 68, 723-728.
24. Peterson, P. K., Molitor, T. W., Chao, C. C. (1998) The opioid-cytokine connection. J. Neuroimmunol. 83, 63-69.
25. Roy, S., Cain, K. J., Chapin, R. B., Charboneau, R. G., Barke, R. A. (1998) Morphine modulated NF kappa B activation in macrophages. Biochem. Biophys. Res. Commun. 245, 392-396.
26. Stefano, G. B. (1996) Opioid and opiate immunoregulatory processes. Crit. Rev. Immunol. 16, 109-144.
27. Zagon, I. S., McLaughlin, P. J. (1981) Heroin prolongs survival time and retards tumor growth in mice with neuroblastoma. Brain Res. Bull. 7, 25-32.
28. Zubelewicz, B., Braczkowski, R., Renshaw, D., Harbuz, M. S. (1999) Central injection of morphine stimulates plasma corticosterone and interleukin (IL)-6 and I1-6 R mRNAs in the pituitary and adrenals in adjuvant-induced arthitis. J. Biol. Regul. Homeost. Agents 13, 103-109.